Swiss Rockets
Group of Companies
Igniting Breakthrough
Biotech Startups
ABOUT
THE GROUP
ABOUT
THE GROUP
ABOUT US
Founded in 2018, the Swiss Rockets Group is an innovative umbrella company with a portfolio of several niche-leading biotech companies ranging from late-stage pre-clinical to Phase III.
MISSION
To identify, invest in and cultivate the most promising biotech startups in Switzerland, Europe, and the US.
BUSINESS MODEL
Accelerating growth of biotech leaders and maximizing impact through mentorship, funding and access (to a wide spectrum of resources, legal and regulatory guidance as well as a broad network of world-class industry experts).
OUR MISSION
Swiss Rockets is dedicated to developing groundbreaking medicines that transform the way cancer, infectious diseases and autoimmune disorders are treated – striving for a more effective, equitable, and accessible healthcare for patients around the world.
Incubator
Services
- Collaboration with cantonal and federal governments
- Access to world-wide scientific experts in their respective fields
- Access to high expertise in legal, regulatory and financial affairs
- Design and operations in preclinical and clinical development, and manufacturing
- Expertise in corporate governance
Accelerator
Services
Accelerate
Designed to accelerate growth and achieve goals.
Provide
Provide financial resources, mentorship, drug development expertise, and guidance on business and management topics.
Support
Designed to accelerate growth and achieve goals.
Experience
Designed to accelerate growth and achieve goals.
Management
Services
Swiss Rockets AG aims to be one of leading incubators and accelerators of biotech startups.
LATEST NEWS
Download Our
Company Factsheet
your name
your email
organization name